WuXi Biologics (Cayman) Inc. (WXIBF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    WuXi Biologics (Cayman) I...

    OTC: WXIBF · Real-Time Price · USD
    4.40
    0.00 (0.00%)
    At close: Aug 26, 2025, 11:47 AM

    WuXi Biologics (Cayman) Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 3.34B 1.5B 1.7B 1.7B 1.89B 3.47B 1.55B 1.84B
    Depreciation & Amortization
    		 653.26M 783.79M 584.69M 584.69M 299.72M 500.95M 149.65M 332.13M
    Stock-Based Compensation
    		 525.45M 690.14M 637.03M 637.03M 697.25M 599.51M 355.33M 222.62M
    Other Working Capital
    		 -1.16B n/a -150.57M -150.57M -100.14M -376.21M -551.77M n/a
    Other Non-Cash Items
    		 201.62M -1.67B -139.55M -139.55M 3.3B -4.18B 3.36B -1.6B
    Deferred Income Tax
    		 n/a n/a n/a n/a 1.3B -1.3B n/a n/a
    Change in Working Capital
    		 -800.5M n/a -448.17M -448.17M -2.1B 1.12B -2.78B n/a
    Operating Cash Flow
    		 3.92B 1.3B 2.33B 2.33B 4.08B 1.46B 2.63B 798M
    Capital Expenditures
    		 -2.06B -1.87B -2.12B -2.12B -3.18B -2.68B -2.43B -4.07B
    Cash Acquisitions
    		 n/a n/a n/a n/a -1.04M -130.44M -145.37M -2.04B
    Purchase of Investments
    		 -11.43B n/a -7.54B -7.54B n/a -10.77B n/a n/a
    Sales Maturities Of Investments
    		 10.89B n/a 7.82B 7.82B n/a 10.49B n/a n/a
    Other Investing Acitivies
    		 -960.58M 1.48B 130.99M 130.99M -360.54M 738.1M 719.77M -1.63B
    Investing Cash Flow
    		 -3.56B -382.52M -1.61B -1.61B -3.55B -2.36B -1.86B -7.74B
    Debt Repayment
    		 490.1M n/a -409.23M -409.23M n/a -295.02M n/a n/a
    Common Stock Repurchased
    		 -531.56M -1.23B -458.46M -458.46M -2.11B -691.06M -2.52B n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 -1.25B -241.19M 1.85B 1.85B -259.25M 767.13M -488.96M 11.22B
    Financial Cash Flow
    		 -1.27B -1.48B 980.58M 980.58M -2.37B -218.94M -3.01B 11.22B
    Net Cash Flow
    		 8.54B -258.16M 3.27B 3.27B -870.03M -2.61B -1.14B 232.75M
    Free Cash Flow
    		 1.85B -565.26M 218.6M 218.6M 899.87M -1.23B 198.58M -3.28B

    Add to Watchlist